Peter Iversen

13.9k total citations
249 papers, 6.0k citations indexed

About

Peter Iversen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Peter Iversen has authored 249 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Pulmonary and Respiratory Medicine, 47 papers in Oncology and 47 papers in Cancer Research. Recurrent topics in Peter Iversen's work include Prostate Cancer Treatment and Research (149 papers), Prostate Cancer Diagnosis and Treatment (119 papers) and Cancer, Lipids, and Metabolism (34 papers). Peter Iversen is often cited by papers focused on Prostate Cancer Treatment and Research (149 papers), Prostate Cancer Diagnosis and Treatment (119 papers) and Cancer, Lipids, and Metabolism (34 papers). Peter Iversen collaborates with scholars based in Denmark, United States and United Kingdom. Peter Iversen's co-authors include Klaus Brasso, Paul O. Madsen, David G. McLeod, Martin Andreas Røder, Reginald C. Bruskewitz, Teuvo L.J. Tammela, Manfred P. Wirth, Kevin Carroll, Ib Jarle Christensen and Klaus Møller‐Ernst Jensen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Peter Iversen

246 papers receiving 5.7k citations

Peers

Countries citing papers authored by Peter Iversen

Since Specialization

Citations

This map shows the geographic impact of Peter Iversen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Iversen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Iversen more than expected).

Fields of papers citing papers by Peter Iversen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Iversen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Iversen. The network helps show where Peter Iversen may publish in the future.

Co-authorship network of co-authors of Peter Iversen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Iversen. A scholar is included among the top collaborators of Peter Iversen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Iversen. Peter Iversen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Whole-body parametric mapping of tumour perfusion in metastatic prostate cancer using long axial field-of-view [15O]H2O PET 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Mads Ryø Jochumsen, Nana Louise Christensen, Peter Iversen, Lars Christian Gormsen, Jens Sørensen, Lars Poulsen Tolbod	2
2	What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review 2020 ·BMJ Open ·(unknown), Signe Benzon Larsen, John Thomas Helgstrand, Peter Iversen, Klaus Brasso, Martin Andreas Røder	5
3	Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL 2017 ·Prostate Cancer and Prostatic Diseases ·Alan H. Bryce, Joshi J. Alumkal, Andrew J. Armstrong, Celestia S. Higano, Peter Iversen, Cora N. Sternberg, Dana E. Rathkopf, Yohann Loriot, Johann S. de Bono, Bertrand Tombal, Sarang Abhyankar, Po‐Han Lin, Andrew Krivoshik, D. Phung, Tomasz M. Beer	71
4	Effect of liraglutide on myocardial glucose uptake and blood flow in stable chronic heart failure patients: A double-blind, randomized, placebo-controlled LIVE sub-study 2017 ·Journal of Nuclear Cardiology ·Roni Nielsen, Anders Jorsal, Peter Iversen, Lars Poulsen Tolbod, Kirsten Bouchelouche, Jens Nørkær Sørensen, Hendrik J. Harms, Allan Flyvbjerg, Lise Tarnow, Caroline Kistorp, Finn Gustafsson, Hans Erik Bøtker, Henrik Wiggers	34
5	The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer 2016 ·European Urology ·Christopher P. Evans, Celestia S. Higano, Thomas E. Keane, Gerald L. Andriole, Fred Saad, Peter Iversen, Kurt Miller, Choung‐Soo Kim, Go Kimura, Andrew J. Armstrong, Cora N. Sternberg, Yohann Loriot, Johann S. de Bono, Sarah B. Noonberg, Hank Mansbach, Suman Bhattacharya, Frank Perabo, Tomasz M. Beer, Bertrand Tombal	66
6	Danish Prostate Cancer Registry – methodology and early results from a novel national database 2016 ·Clinical Epidemiology ·John Thomas Helgstrand, (unknown), Martin Andreas Røder, Birgitte Grønkær Toft, Klaus Brasso, Ben Vainer, Peter Iversen	24
7	ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer 2015 ·Journal of Clinical Pathology ·Kasper Drimer Berg, Klaus Brasso, Frederik Birkebæk Thomsen, Martin Andreas Røder, (unknown), Birgitte Grønkær Toft, Peter Iversen, Ben Vainer	9
8	Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [11C]acetate in humans 2014 ·Frontiers in Neuroscience ·Peter Iversen, Kim Mouridsen, Mikkel Bo Hansen, Svend Borup Jensen, (unknown), Lasse K. Bak, Helle S. Waagepetersen, Arne Schousboe, Peter Ott, Hendrik Vilstrup, Susanne Keiding, Albert Gjedde	17
9	Prospective assessment of urinary, gastrointestinal and sexual symptoms before, during and after image-guided volumetric modulated arc therapy for prostate cancer 2014 ·Scandinavian Journal of Urology ·(unknown), Anders Widmark, Per Fransson, Peter Iversen, Per Munck af Rosenschöld, Svend Aage Engelholm, René Horsleben Petersen	5
10	Patients undergoing radical prostatectomy have a better survival than the background population. 2013 ·PubMed ·Martin Andreas Røder, Klaus Brasso, Kasper Drimer Berg, Frederik Birkebæk Thomsen, (unknown), (unknown), Peter Iversen	5
11	Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort 2013 ·European Journal of Cancer ·Signe Benzon Larsen, Klaus Brasso, Peter Iversen, Jane Christensen, Michael Christiansen, Sigrid Carlsson, Hans Lilja, Søren Friis, Anne Tjønneland, Susanne Oksbjerg Dalton	8
12	Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer 2010 ·The Prostate ·(unknown), Klaus Brasso, Peter Iversen, Helle Pappot, Gunilla Høyer‐Hansen, Keld Danø, Ib Jarle Christensen	47
13	Screening for prostatacancer--hvad siger evidensen? 2007 ·Ugeskrift for Læger ·Michael Borre, Peter Iversen	1
14	Determining the dose of degarelix for effective therapy of prostate cancer patients as investigated by the degarelix study groups 2006 ·Annals of Oncology ·Bertrand Tombal, Peter Iversen, Hendrik Van Poppel, Teuvo L.J. Tammela, Jean J. de la Rosette, Jan‐Erik Johansson, Bo‐Eric Persson, Jens-Kristian Jensen, Tine Kold Olesen	2
15	Bicalutamide (‘Casodex’) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme 2005 ·Radiotherapy and Oncology ·C. Tyrrell, (unknown), William A. See, David G. McLeod, Manfred P. Wirth, Peter Iversen, J. Armstrong, Clive Morris	50
16	Is the efficacy of hormonal therapy affected by lymph node status? data from the bicalutamide (Casodex) Early Prostate Cancer program 2004 ·Urology ·Peter Iversen, Manfred P. Wirth, William A. See, David G. McLeod, Ira Klimberg, Donald M. Gleason, Gerald W. Chodak, James E. Montie, C. Tyrrell, D. M. A. WALLACE, K.P.J. Delaere, (unknown), Teuvo L.J. Tammela, Jan‐Erik Johansson, Tom Morris, Kevin Carroll	12
17	A Randomised Comparison of ‘Casodex’<sup>TM</sup> (Bicalutamide) 150 mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer 1998 ·European Urology ·CJ Tyrrell, Amir Kaisary, Peter Iversen, John Anderson, L. Baert, Teuvo L.J. Tammela, M. C. Chamberlain, Angela C Webster, G. Blackledge	223
18	Seminal plasma PSA in spinal cord injured men: a preliminary report 1998 ·Spinal Cord ·Klaus Brasso, Jens Sønksen, Peter Sommer, Lars Ødum, Fin Biering‐Sørensen, Peter Iversen, Jørgen Kvist Kristensen	15
19	Comparability of prostate trials 1993 ·Cancer ·Stefan Suciu, R. Sylvester, Peter Iversen, Ib Jarle Christensen, L. Denis	7
20	Bacterial adherence to urothelium following bladder irrigation in the rat 1982 ·Infection ·Peter Iversen, Paul O. Madsen	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact